• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sci Rep . A novel deep learning-based quantification of serial chest computed tomography in Coronavirus Disease 2019 (COVID-19)

tetano

Editor, Senior Moderator
Sci Rep


. 2021 Jan 11;11(1):417.
doi: 10.1038/s41598-020-80261-w.
A novel deep learning-based quantification of serial chest computed tomography in Coronavirus Disease 2019 (COVID-19)


Feng Pan[SUP] 1 2 [/SUP], Lin Li[SUP] 1 2 [/SUP], Bo Liu[SUP] 3 4 [/SUP], Tianhe Ye[SUP] 1 2 [/SUP], Lingli Li[SUP] 1 2 [/SUP], Dehan Liu[SUP] 1 2 [/SUP], Zezhen Ding[SUP] 3 4 [/SUP], Guangfeng Chen[SUP] 1 2 [/SUP], Bo Liang[SUP] 1 2 [/SUP], Lian Yang[SUP] 5 6 [/SUP], Chuansheng Zheng[SUP] 1 2 [/SUP]



Affiliations

Abstract

This study aims to explore and compare a novel deep learning-based quantification with the conventional semi-quantitative computed tomography (CT) scoring for the serial chest CT scans of COVID-19. 95 patients with confirmed COVID-19 and a total of 465 serial chest CT scans were involved, including 61 moderate patients (moderate group, 319 chest CT scans) and 34 severe patients (severe group, 146 chest CT scans). Conventional CT scoring and deep learning-based quantification were performed for all chest CT scans for two study goals: (1) Correlation between these two estimations; (2) Exploring the dynamic patterns using these two estimations between moderate and severe groups. The Spearman's correlation coefficient between these two estimation methods was 0.920 (p < 0.001). predicted pulmonary involvement (CT score and percent of pulmonary lesions calculated using deep learning-based quantification) increased more rapidly and reached a higher peak on 23rd days from symptom onset in severe group, which reached a peak on 18th days in moderate group with faster absorption of the lesions. The deep learning-based quantification for COVID-19 showed a good correlation with the conventional CT scoring and demonstrated a potential benefit in the estimation of disease severities of COVID-19.
 
Back
Top Bottom